Private Equity Revolutionizing Healthcare: Oregon’s New Law and Nationwide Ramifications
In the ever-evolving landscape of U.S. healthcare, the rise of private equity (PE) firms has been both a boon and a point of contention. On June 9, 2025, Oregon Governor Tina Kotek signed Senate Bill 951 (SB 951) into law, marking a significant step in restricting private equity investment in healthcare.
### The Rise Of Private Equity In U.S. Healthcare
Private equity investments involve firms or individuals injecting capital into private companies to enhance their value and ultimately sell them for a profit. In healthcare, this trend has seen a significant surge, with PE firms now owning 460 hospitals, a 25-fold increase over the past two decades. From 2010 to 2020, private equity deals in healthcare soared by over 250%.
This growth can be attributed to the perceived inefficiencies in healthcare processes and the sector’s attractiveness due to its size, valuable assets, and stable demand. However, concerns have been raised about the impact of PE acquisitions on patient care quality. A study published in JAMA reported a significant increase in patient safety incidents following PE acquisitions of hospitals.
### Why Are Physicians Turning To Private Equity?
For some physicians, particularly those nearing the latter stages of their careers, private equity offers an attractive exit strategy. Rising operational costs and declining reimbursement rates from insurers have made it challenging for medical practices to sustain profitability. Private equity presents an opportunity for senior physicians to monetize their assets and transition out of the market with substantial compensation.
### What Are The Risks Of Private Equity In Healthcare?
The concerns surrounding private equity in healthcare primarily revolve around the impact on patient care quality. PE firms often target high-margin specialties and procedures, leading to cost-cutting measures that can compromise clinical outcomes. The implementation of management fees and debt assumption requirements for surgeons under PE ownership adds another layer of risk to the equation.
### How Is Oregon Limiting Private Equity In Healthcare?
Oregon’s SB 951 aims to curb the influence of private equity in healthcare by strengthening regulations on the corporate practice of medicine. The law prohibits non-physicians from owning or controlling medical practices, focusing on management service organizations (MSOs) commonly used by PE firms for investment. MSOs are now restricted from interfering in clinical decisions and must adhere to fair market value fee caps.
### Nationwide Ramifications of Oregon’s New Law
Oregon’s bold stance on regulating private equity in healthcare through SB 951 may pave the way for other states to follow suit. Recent health system bankruptcies involving PE-backed entities have heightened the call for stricter oversight on the corporate practice of medicine. The nationwide implications of Oregon’s new law underscore the growing debate on the role of private equity in the healthcare sector.
### The Future of Private Equity in Healthcare
As the healthcare industry grapples with the impact of private equity investments, the fundamental question remains: who should be entrusted with the stewardship of healthcare? Oregon’s SB 951 reinforces the importance of patient-physician trust and raises broader discussions on the limits of state intervention in complex healthcare systems. Moving forward, striking a balance between regulatory oversight and fostering innovation in healthcare delivery will be crucial in navigating the evolving landscape of private equity in the medical sector.
